Know Cancer

or
forgot password


N/A
25 Years
45 Years
Not Enrolling
Female
Ovarian Cancer

Thank you

Trial Information


Inclusion Criteria:



- Women seeking for tubal sterilisation

Exclusion Criteria:

- women older than 45

- family history of ovarian cancer

- presence of menopausal symptoms

- irregular cycles

- Hormone Replacement Therapy or hormone contraceptions the last 3 months

- history of previous ovarian or uterine surgeries

- imaging suggesting an ovarian cyst or other adnexal pathology during investigation

- previous salpingectomy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)

Outcome Time Frame:

3 months

Safety Issue:

Yes

Authority:

Sweden: Regional Ethical Review Board

Study ID:

SEvsTSinAMH

NCT ID:

NCT01888159

Start Date:

September 2013

Completion Date:

Related Keywords:

  • Ovarian Cancer
  • Ovarian Neoplasms

Name

Location